F095 Skin and Systemic Malignancy
DESCRIPTION
The intersection between systemic malignancy is a rich, varied, and dynamic territory, familiarity with which is critical for the dermatologist. As “window to the soul,” the skin can reveal systemic malignancy via cutaneous metastases, genodermatoses, infections, or paraneoplastic dermatoses. Conversely, cancer therapeutics, including agents of complementary/alternative medicine, can induce significant cutaneous effects. Surgical therapeutics play a critical role in optimal management of cutaneous issues of systemic malignancy. These topics will be explored in this forum through discussion of patient cases with audience participation, aiming to enhance the attendee’s approach to detection, work-up, and care of patients with suspected skin signs of systemic malignancy, to better manage mucocutaneous effects of systemic therapy, and to optimally employ surgical tools in dermato-oncology. Mention of the future of the field, including the potential role of augmented intelligence will also be discussed. This
LEARNING OBJECTIVES
Identify skin manifestations of systemic malignancy presenting as various paraneoplastic dermatoses, infections, genodermatoses, and skin metastases.
Recognize the spectrum of cutaneous effects (including drug reactions, cutaneous infections, etc) of therapeutics for systemic malignancy, including agents of alternative/complementary medicine, with mention of the potential future role of augmented intelligence in dermato-oncology.
Summarize optimal surgical approaches to dermato-oncologic issues.
SCHEDULE
3:30 PM
Introduction & Overview
Vincent Liu, MD, FAAD
3:35 PM
Paraneoplastic Dermatoses & Cutaneous Metastases
Vincent Liu, MD, FAAD
3:55 PM
Rashes and Other Mucocutaneous Effects of Cancer Therapy
Bernice Kwong, MD, FAAD
4:20 PM
Surgical Approach to Dermato-oncology
Nkanyezi Ngwenyama Ferguson, MD, FAAD
4:40 PM
Skin Infections and Systemic Malignancy
Jina Chung, MD, FAAD
5:05 PM
Complementary/Alternative Medicine, Augmented Intelligence, and Skin & Systemic Malignancy
Peter A. Lio, MD, FAAD
DIRECTOR
Vincent Liu, MD, FAAD
SPEAKERS
Jina Chung, MD, FAAD
Nkanyezi Ngwenyama Ferguson, MD, FAAD
Bernice Kwong, MD, FAAD
Peter A. Lio, MD, FAAD
HANDOUTS
DISCLOSURES
Jina Chung, MD, FAAD
No financial relationships exist with ineligible companies.
Nkanyezi Ngwenyama Ferguson, MD, FAAD
No financial relationships exist with ineligible companies.
Bernice Kwong, MD, FAAD
Happy 2nd Birthday, Inc – Consultant(Fees), Consultant(No Compensation Received); Novartis – Consultant(Fees); Novocure – Investigator(No Compensation Received); OncoDerm LLC – Consultant(No Compensation Received);
Peter A. Lio, MD, FAAD
AbbVie – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Akeyna, Inc. – Advisory Board(Stock Options); Almirall – Advisory Board(Fees), Speaker(Fees); Alphyn Biologics – Advisory Board(Honoraria); Amyris, Inc. – Consultant(Fees); AOBiome, LLC – Investigator(Grants/Research Funding); Apogee Therapeutics – Advisory Board(Fees); Arcutis Biotherapeutics – Speaker(Fees); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Advisory Board(Fees); Astria Therapeutics – Advisory Board(Honoraria); AvantGuard – Board of Directors(Stock Options); Boston Skin Science LLC – Advisory Board(Stock); Bristol-Myers Squibb – Advisory Board(Fees); Burt's Bees – Consultant(Fees); Castle Biosciences – Advisory Board(Fees); ClearRx – Advisory Board(Stock Options); Codex Labs – Advisory Board(Stock Options); Concerto Biosciences – Consultant(Stock Options); DermVeda – Advisory Board(Stock Options); Eczema Foundation (Formerly La Fondation pour la Dermatite Atopique) – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees), Speaker(Fees); Galderma Laboratories, LP – Advisory Board(Fees); Galderma USA – Speaker(Honoraria); Hyphens Pharma – Speaker(Honoraria); Incyte Corporation – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Johnson & Johnson Consumer Products Company – Advisory Board(Honoraria); Kenvue – Advisory Board(Fees); Kimberly Clark – Consultant(Fees); L'Oreal USA Inc. – Consultant(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker(Honoraria); LearnHealth/LearnSkin – Stockholder(Stock Options); LEO Laboratories Ltd (LEO Pharma) – Consultant(Fees); Leo Pharma Inc – Speaker(Fees); Lipidor – Consultant(Fees); Medable – Stockholder(Stock Options); Modernizing Medicine – Stockholder(Stock Options); MyOR Diagnostics Ltd – Consultant(Fees), Speaker(Honoraria); National Eczema Association – Board of Directors(No Compensation Received); Nektar Therapeutics – Advisory Board(Fees); NiaHealth – Advisory Board(Fees); Novartis – Advisory Board(Fees); ParentMD – Speaker(Patent royalties or other compensation for Intellectual Property Rights); Pelthos Therapeutics – Advisory Board(Fees); Pfizer Inc. – Speaker(Honoraria); Phyla (Phi Therapeutics) – Advisory Board(Honoraria); Pierre Fabre Dermatologie – Speaker(Honoraria); Regeneron – Advisory Board(Fees), Speaker(Fees); Sanofi US Services – Advisory Board(Honoraria); Sibel Health – Consultant(Fees); Skinesa – Consultant (1099 relationship)(Fees); Skinfix, Inc. – Consultant(Fees); Song Lab Skincare – Advisory Board(Stock Options); Sonica LLC – Consultant(Fees); SOTERI SKIN, INC. – Advisory Board(Stock Options); Stratum Biosciences – Advisory Board(Stock Options); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Syncere Skin Systems – Advisory Board(Stock Options); Theraplex – Consultant(Fees), Other(Patent royalties or other compensation for Intellectual Property Rights); Thimble Health – Advisory Board(Stock Options); Topaz Biosciences, Inc. – Advisory Board(Stock Options); UCB – Advisory Board(Honoraria); Verdant Scientific, Inc. – Advisory Board(Stock Options); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria), Speaker(Fees); YobeeCare Inc. – Advisory Board(Stock Options); Zenzema – Speaker/Faculty Education(Fees);
Vincent Liu, MD, FAAD
Springer Publishing – Other(Patent royalties or other compensation for Intellectual Property Rights); WoltersKluwer Health – Other(Patent royalties or other compensation for Intellectual Property Rights);